Clinical Trial

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Recruiting
View on ClinicalTrials.gov →
Summary
The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as their cochlear implant manufacturer of choice for their upcoming surgery. The aim of this study is to determine if 1) patient outcomes remain stable when reducing follow-up appointments and 2) Cochlear's population mean mapping can produce similar outcomes with patients while additionally reducing appointment times. The hypothesis is that using population mean mapping and reducing the number of follow-up visits after activation will yield similar performance outcomes to a standard of care while decreasing the length of appointment times and number of appointments needed for each patient.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-05; most recent amendment 2026-05-18.
Trial Details
NCT Number NCT06960616
Lead Sponsor Massachusetts Eye and Ear Infirmary
Collaborators: Cochlear
Conditions Deafness, Cochlear Hearing Loss
Enrollment 48 participants
Start Date 2024-02-27
Primary Completion 2026-11-26 (estimated)
Study Completion 2027-02-26 (estimated)
Updated on ClinicalTrials.gov 2026-05-20